Skip to main content

Alnylam Pharmaceuticals (NQ: ALNY )

255.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 9, 2024 Add to My Watchlist

Other Filings

Form 424B5
Source: SEC/Edgar
January 15, 2013
Form 8-K
Source: SEC/Edgar
January 15, 2013
Form 8-K
Source: SEC/Edgar
January 13, 2013
Form 424B5
Source: SEC/Edgar
January 13, 2013
Form 8-K
Source: SEC/Edgar
January 06, 2013
Form S-3ASR
Source: SEC/Edgar
December 20, 2012
Form CT ORDER
Source: SEC/Edgar
November 13, 2012
Form 8-K
Source: SEC/Edgar
November 12, 2012
Form 8-K
Source: SEC/Edgar
November 04, 2012
Form 8-K
Source: SEC/Edgar
October 21, 2012
Form 8-K
Source: SEC/Edgar
September 25, 2012
Form 8-K
Source: SEC/Edgar
September 24, 2012
Form 8-K
Source: SEC/Edgar
August 27, 2012
Form 8-K
Source: SEC/Edgar
August 05, 2012
Form 8-K
Source: SEC/Edgar
June 26, 2012
Form CT ORDER
Source: SEC/Edgar
June 19, 2012
Form ARS
Source: SEC/Edgar
May 06, 2012
Form 8-K
Source: SEC/Edgar
May 02, 2012
Form DEF 14A
Source: SEC/Edgar
April 26, 2012
Form 8-K
Source: SEC/Edgar
April 22, 2012
Form 8-K
Source: SEC/Edgar
March 27, 2012
Form 8-K
Source: SEC/Edgar
March 06, 2012
Form 8-K
Source: SEC/Edgar
February 15, 2012
Form 8-K
Source: SEC/Edgar
February 14, 2012
Form 424B5
Source: SEC/Edgar
February 14, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form SC 13G/A
Source: SEC/Edgar
February 13, 2012
Form 424B5
Source: SEC/Edgar
February 12, 2012
Form SC 13G/A
Source: SEC/Edgar
February 12, 2012
Form 8-K
Source: SEC/Edgar
February 08, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.